| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $22,066 | +1,100 | +2.4% | $20.06* | 47,350 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $151,195 | -1,100 | -2.3% | $137.45 | 46,250 | 07 Feb 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $20,642 | +1,029 | +2.2% | $20.06* | 47,279 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $142,681 | -1,029 | -2.2% | $138.66 | 46,250 | 07 Feb 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $47,562 | +2,371 | +5.1% | $20.06* | 48,621 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $330,565 | -2,371 | -4.9% | $139.42 | 46,250 | 07 Feb 2022 | Direct | F1, F2, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1,100 | -13% | $0.000000 | 7,400 | 07 Feb 2022 | Common Stock | 1,100 | $20.06 | Direct | F6 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1,029 | -14% | $0.000000 | 6,371 | 07 Feb 2022 | Common Stock | 1,029 | $20.06 | Direct | F6 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2,371 | -37% | $0.000000 | 4,000 | 07 Feb 2022 | Common Stock | 2,371 | $20.06 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $137.03 to $137.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $138.03 to $139.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $139.20 to $139.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Options were fully vested on 5/17/13. |